Frontline health workers caring for patients with the novel coronavirus disease (COVID-19) may benefit from effective interventions derived from previous emerging virus outbreaks, which can be employed to help mitigate psychological distress, suggest the results of a rapid review and meta-analysis.
Mood homeostasis appears to be impaired in people with low mood and a history of depression, a recent study has shown. These results may provide new insights to guide the development of treatments for depression.
A Chinese cross-sectional case-control study has identified time spent following news on coronavirus disease 2019 (COVID-19) and drug-resistant epilepsy as two independent predictors of severe psychological distress among epilepsy patients during the COVID-19 pandemic.
The European Cognitive Behaviour Therapy for Insomnia (CBT-I) Academy has issued practical recommendations, adapted from elements of cognitive behavioural therapy (CBT), on dealing with sleep problems during home confinement due to the coronavirus disease 2019 (COVID-19) outbreak for those facing changed work schedules and requirements, those with health anxiety, and those handling childcare and homeschooling.
Frontline healthcare workers who are directly diagnosing, treating, or caring for patients with COVID-19 have increased risks for depression, anxiety, insomnia, and distress, according to a study from China.
Researchers in Singapore have synthesized in a recent review several psychological responses seen across infectious disease outbreaks in the past, including anxiety, depression, loss, stigmatization, isolation and cognitive restructuring.
Post hoc analyses of the LIBERTY AD SOLO 1 & 2* and ADOL** trials demonstrated significant reductions in pruritus, anxiety, and depression with dupilumab in adults and adolescents with moderate-to-severe atopic dermatitis (AD).